Recombinate - analogs
Components: Octocog alfa |
|||||||||
| Prices in pharmacies: — Instructions Recombinate | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | Advate | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 74% — Kogenate FS [Octocog alfa and more 1Blood clotting Factor VIII]
- 65% — Refacto AF [Moroctocog alfa]
- 65% — Hemlibra [Emicizumab]
- 65% 69.2€ Octofactor [Moroctocog alfa]
- 60% — Agemfil B [Blood Clotting Factor IX]
- 59% 0.1€ Koate-HP [Blood clotting Factor VIII]
- 59% — Иннонафактор [Nonacog alfa]
- 56% 35.6-136€ Octanat [Blood clotting Factor VIII and more 1Proteine]
- 56% — Octanine [Blood Clotting Factor IX and more 1Proteine]
- 54% — Cryoprecipitate [Blood clotting Factor VIII]
- 52% — Octavi [Blood clotting Factor VIII and more 1Proteine]
- 49% — Gelaspon [Formaldehyde]
- 49% — Hemofil M [Blood clotting Factor VIII]
- 49% — Kryobulin TIM 3 [Blood clotting Factor VIII and more 1Alanine]
- 49% — Koate-DVI [Blood clotting Factor VIII]
- 49% 73-200€ Immunate [Blood clotting Factor VIII]
- 46% — Konyne 80 [Coagulation Factor II, VII, IX and X in combination [Prothrombin complex] and more 2Factor IX complex, Coagulation Factor VII]
- 45% 250€ Protromplex 600 [Coagulation Factor II, VII, IX and X in combination [Prothrombin complex] and more 2Coagulation Factor VII, Factor IX complex]
- 45% 162.8€ NovoSeven [Eptacog alfa (activated)]
- 45% — Feiba [Anti-inhibitor Coagulant Complex]
- 45% — Eloctate [Efmoroctocog alfa]
- 44% 264.7-785€ Coagil-VII [Eptacog alfa (activated)]
- 44% — АриоСэвен [Eptacog alfa (activated)]
- 44% — Eptacog alfa (activated) [Eptacog alfa (activated)]
- 43% — Antihemophillic factor human-M (AHF-M) [Blood clotting Factor VIII]
- 43% — Emoclot D.I [Blood clotting Factor VIII]
- 43% — Haemate P [Blood clotting Factor VIII]
- 43% — Эйтоплазм [Blood clotting Factor VIII]
- 43% — Bebulin TIM 4 [Blood Clotting Factor IX and more 2Proteine, Alanine]
- 43% — Beriate [Blood clotting Factor VIII]
- 42% 35-137€ Octanine F (filtered) [Blood Clotting Factor IX]
- 40% — Feracryl [Ferric polyacrylate]
- 40% — Железа полиакрилат [Ferric polyacrylate]
- 40% — Agemfil A [Blood clotting Factor VIII]
- 39% 9.6-9.7€ Protamine sulfate [Protamine sulfate]
- 39% — Octaplex [Coagulation Factor II, VII, IX and X in combination [Prothrombin complex] and more 2Coagulation Factor VII, Factor IX complex]
- 39% — Protamine sulfate solution for injections [Protamine sulfate]
- 39% — Coaplex [Coagulation Factor II, VII, IX and X in combination [Prothrombin complex] and more 2Coagulation Factor VII, Factor IX complex]
- 39% — Trombinum [Trombin]
- 39% — Wilfactin [Willebrand factor]
- 39% — Протагем [Protamine sulfate]
- 38% 135-190€ Nplate [Romiplostim]
- 38% — Ромиплостим-ГЕРОФАРМ [Romiplostim]
- 38% 230€ Стимплейт [Romiplostim]
- 37% — Haemoctin [Blood clotting Factor VIII]
- 36% — Протамин-Бинергия [Protamine sulfate]
- 36% — Protamine-Ferein [Protamine sulfate]
- 36% — Протамин [Protamine sulfate]
- 34% 0.2€ Vicasol [Menadione sodium bisulfite]
- 34% 0.6€ Vikasol-Darnitsa [Menadione sodium bisulfite]
Learn more about the selection of analogues
▶
- The drug has «Recombinate» 1 full analog, for example Advate; 51 analog by action, the most similar - Octofactor (69.2€).
- Medical online service has selected the best substitutes for Recombinate based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Recombinate to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.